Haab, Brian B.

The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis

Staal, B., Liu, Y., Barnett, D., Hsueh, P., He, Z., Gao, C., Partyka, K., Hurd, M. W., Singhi, A. D., Drake, R. R., et al. (2019) · Clinical Cancer Research

Pancreatic and Hepatic Oncology ResearchGlycosylation and Glycoproteins Research

Cited by 49

Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN

Liu, Y., Kaur, S., Huang, Y., Fahrmann, J. F., Rinaudo, J. A., Hanash, S. M., Batra, S. K., Singhi, A. D., Brand, R. E., Maitra, A., et al. (2020) · Cancer Epidemiology, Biomarkers & Prevention

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 17

Mesenchymal‐like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial‐like counterparts

Sinha, A., Cherba, D., Bartlam, H., Lenkiewicz, E., Evers, L., Barrett, M. T., & Haab, B. B. (2014) · Molecular Oncology

Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics

Cited by 11